Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation.

Victor A de VriesJan PalsHuub J PoelmanParinaz RostamzadRoger C W WolfsWishal D Ramdas

Published in: Journal of clinical medicine (2022)

MP-TSCPC is a safe and effective treatment option for lowering IOP, but only reduced IOP-lowering medications in the first 6 months after treatment. However, MP-TSCPC is especially effective in getting patients off oral IOP-lowering drugs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes